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ABSTRACT:
Regulatory regions in the genome can act through a variety
of mechanisms that range from the occurrence of histone
modifications to the presence of protein-binding loci for self-
annealing sequences. The final result is often the induction
of a conformational change of the DNA double helix, which
alters the accessibility of a region to transcription factors
and consequently gene expression. A 300 kb regulatory
region on chromosome 14 at the 3’ end (3’RR) of immuno-
globulin (Ig) heavy-chain genes shows very peculiar features,
conserved in mammals, including enhancers and transcrip-
tion factor binding sites. In primates, the 3’RR is present in
two copies, both having a central enhancer named hs1.2.
We previously demonstrated the association between differ-
ent hs1.2 alleles and Ig plasma levels in immunopathology.
Here, we present the analysis of a putative G-quadruplex
structure (tetraplex) consensus site embedded in a variable
number tandem repeat (one to four copies) of hs1.2 that is a
distinctive element among the enhancer alleles, and an
investigation of its three-dimensional structure using bioin-
formatics and spectroscopic approaches. We suggest that
both the role of the enhancer and the alternative effect of the
hs1.2 alleles may be achieved through their peculiar three-
dimensional-conformational rearrangement.VC 2017 The
Authors Biopolymers Published by Wiley Periodicals, Inc.
Biopolymers 105: 768–778, 2016.
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INTRODUCTION
A
relevant role of noncoding and intergenic regions
in the human genome control has been recognized
for many years. Emphasis has been given to the
function of these regions in genetic regulation.1–3
This task is achieved either through binding of spe-
cific proteins or through inducing specific DNA conforma-
tions, which result in the control of entire coding regions.4,5
We are interested in understanding how the 3’ regulative
region (3’RR) of immunoglobulin heavy chain gene cluster
(IgH) works. During B-cell maturation, the 3’RR plays funda-
mental control roles for somatic hypermutation, and in class
switch through epigenetic changes of chromatin.6,7 The 3’RR is
present in a single copy in nonprimate mammals, while is
duplicated in human on chromosome 14, and in most primate
species on related syntenic regions.8 Despite synteny among
3’RRs in different mammals, these regions can harbor three
enhancers (hs1.2, hs3, and hs4) as in humans, or four
enhancers, one of the original three being duplicated, as in
rodents, in which also three insulators (hs5, hs6, and hs7) are
present in a lineage-specific sequence.9 In all species, hs1.2
maps to the central conserved core of the 3’RRs. In the
genomes harboring the duplication, binding sites for specific
transcription factors like NF-kB and Sp1, are conserved in
both the paralogous copies of the hs1.2 enhancer.8 These sites
and their peptidic interactors are thought to play a crucial role
both in the isotipic switch and in correct Ig transcription at
different stages of B-cell development.6,7,10–13 In agreement
with these findings, we demonstrated that human polymor-
phisms of hs1.2 enhancer in 3’RR1 are associated with the
humoral-response control of Ig-circulating levels and with
autoimmune diseases.14–16 Moreover, an imbalance of allele
frequency is observed in celiac disease, psoriasis, systemic scle-
rosis, rheumatoid arthritis, and lupus erythematosus patients
when compared with healthy controls.16–20
Despite their inferred role, we still lack knowledge of the
structural and functional details of 3’RRs. In vivo experiments,
like fluorescence in situ hybridization and chromosome con-
formation capture, confirmed a large conformational rear-
rangement of the DNA, although these methods did not
provide specific structural information.4,21 A first insight into
the three-dimensional (3D) structure of the 3’RR was given by
previous in silico studies that showed the presence of an
inverted duplication. As a palindromic sequence, the inverted
duplication may give rise to a hairpin-loop shape, in which the
hs1.2 enhancer is located at the apical loop.8,22,23 The inverted
duplication can be recognized in all mammals studied so far,
although it does not show similarity among species belonging
to different orders, supporting the hypothesis of a function
linked to specific 3D structures.8,24 The hypothesized 3D struc-
ture locates the hs1.2 enhancer in the middle of a loop where
the DNA is supposed to assume single-stranded conformation.
The human version of this enhancer has allelic variants with an
internal Variable Number Tandem Repeat (VNTR), consisting
of a 40 nucleotides element (40-mer) repeated from one to
four times. Studies aimed at defining a list of the human
genetic variations using whole genome and multigenome
approaches seem to fail to highlight the peculiarity of these
VNTR until recently.25 The 40-mer contains a binding site for
NF-kB and SP1, as demonstrated by electrophoretic mobility
shift assays.14,19,26 This finding suggests a relevant biological
role of the enhancer.
In this work, we analyze in detail a 17-nucleotides DNA
sequence (17-mer) spanning a portion of the enhancer
hs1.2 that is predicted to form a quadruplex. The 17-mer
maps just upstream to the NF-kB and SP1 binding sites
and, as a potential quadruplex, can have a relevant regula-
tive role on adjacent transcription factors. Genome wide
analyses indeed reported both the proximity of putative
quadruplex sequence to transcription factor consensus
sites27 and the association between polymorphisms on
quadruplex locus and gene expression.28,29 Using our
strategy, that combines sequence and spectroscopic analy-
sis, we confirmed the ability of this DNA sequence to form
in vitro a quadruplex structure and showed that this fea-
ture of the enhancer is preserved from evolutionary diver-
gence. This short sequence is thus a strong candidate to
constitute a further fundamental component that finely
tunes the hs1.2 activity with protein binding properties
similar to many regulatory regions as reported by genomic
studies.30
RESULTS
Analysis of 3’RRs and hs1.2 Main Features, and
Schematization of Human Structures
Figure 1 shows a scheme of the human regulative regions
(3’RR1 and 3’RR2), located downstream of the IgH a-gene,
ranging from a broad view (Figures 1A and 1B) to details of
the nucleotide sequence of the main untranslated feature of the
regions, i.e. the enhancer hs1.2 (Figure 1C).
We first considered dbSNP build 13731 to investigate the
possibility of distinguishing the two paralogous copies of the
3’RR in human NGS data which would give us the chance to
discern the two loci in 1K Genome Project data. We concluded
that it is impossible to distinguish between the two copies
because of the high level of similarity between the 3’RR1 and
3’RR2. Figure 1B, indeed, shows SNPs in the enhancer regions,
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distinguishing between those which map to a single genomic
region from those mapping in multiple genomic loci (multilo-
cus), as reported in dbSNP build 137. Our preliminary re-
sequencing trial (data not shown) of 3’RR2 indicate that some
of the SNPs labeled as “single” are probably multilocus or
misassigned, beside the already conspicuous number of multi-
locus SNPs indicated in the figure. These findings suggest
uncertainty about the SNP locations making it impossible to
distinguish if both, either or neither of the 3’ RRs is conserved
within the human species. A possible explanation is that the
alignment of short reads from massive sequencing to a refer-
ence genome and the consequent identification of polymor-
phic loci are error-prone in regions that are duplicated such as
the 3’RR, and especially close to the hs1.2 enhancers, because
of the high similarity level between its evolutionary-recent
paralogous copies.
The hs1.2 enhancer maps to the conserved center of each
3’RR copy (Figure 1B). The core and tail fragments of the
enhancer are the more and the less conserved regions of this
functional sequence, respectively, when mammal DNAs are
compared with each other.8 Between core and tail of hs1.2 there
is a region that, in Catarrhini’s variant, showed multiple alleles
due to an embedded VNTR of 40 nucleotides, repeated in
human version of the enhancer from one to four times. This 40-
mer contains binding sites for transcription factors, among
which are NF-kB and SP1 (Figure 1C), known as mainly
involved in cellular responses to stimuli such as bacterial or viral
antigens and to a growing list of cellular stresses.32 Moreover,
the 40-mer contains a putative G-quadruplex site. The multipli-
cation of the 40-mer in the various alleles is thus responsible for
the proliferation of sequence of putative transcription-factor-
binding and G-quadruplex sites within the enhancer.
FIGURE 1 Human 3’RRs and hs1.2-sequence details. (A) Graphic details of the human Ig con-
stant region (C region), harboring the two copies of the 3’ Regulatory Region (3’RR1 and 3’RR2) as
part of extended in-tandem duplication involving most of the C region. In the two regulatory
regions, the two blocks of both palindrome1 (enlarged in section B) and palindrome2 are the
inverted repeated branches of the palindromes cited in the text. Internal to both the 3’RRs are the
three enhancers, respectively hs3, hs1.2, and hs4, in orange. The blue arrow shows the transcription
direction of the Ig genes. In the two bottom lines, the positions of SNPs from the dbSNP build 137.
(B) Portion of the human 3’RR1 in higher detail. In green the two branches of the conserved palin-
dromic sequence, embedding a region including hs1.2 with the potential to fold in a big loop of a
hairpin structure. (C) Sequences of hs1.2 allele *1 and *2, illustrating VNTR structure, transcrip-
tion factor consensus sites, and quadruplex putative sites. The main difference between the two iso-
form is the presence of a different number of the 40mer and C rich elements.
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Conservation Among Mammals of G-Quadruplex
Predicted in hs1.2
Bioinformatics evidence shows that putative quadruplex
regions are often found close to transcription factor binding
sites.30,33 We thus scanned the 3’RRs in search of putative
quadruplex sites and we found evidence for it within hs3,
hs1.2, and hs4, the 3’RRs enhancers that are rich in transcrip-
tion factor binding sites. We focused our attention on the G-
quadruplex inside hs1.2 because of its multiple copies, a feature
observed in most primates.8 In fact, we noted that the four
pairs of guanines putatively forming the quadruplex, are in the
VNTR element (Figure 1C), and downstream from a core
sequence highly conserved in mammals.8 Figure 1C reports
the 17-mer (GGCCAGGCTGGCCCAGG labeled as SAwt)
including the four GG-pairs within the hs1.2 enhancer that
was predicted to form the G-quadruplex. By comparing
sequences available in the GenBank database, we found that
the SAwt sequence within the hs1.2 is highly conserved among
mammals (Table I), with a strong constraint on the guanine
pairs necessary for the formation of the quadruplex structure.
Some species show the contemporary loss of one of the
“canonical” G-pair, and gain of a new G-pair, so the potential
to form quadruplex in the 40-mer is unaltered. This finding
confirms a restriction to the variability of these four pairs of
nucleotides and, consequently, the putative functional role of
this element in the enhancer sequence. It should be noted that
mouse is the only species that has lost two of the G-pairs in the
40-mer, so the quadruplex site might actually not be present in
mice. The rodents, however, evolved a peculiar regulatory
mechanism involving three lineage-specific insulators9 that
could complement the quadruplex absence.
Native Electrophoresis of the Putative Quadruplex
Regions
In order to get insights on the behavior in solution of the SAwt
sequence, we performed native polyacrylamide gel electropho-
resis (PAGE). We decided to buffer the solutions with potas-
sium as a counter-ion to exploit the known tendency of this
ion to stabilize quadruplex formation through its ability to
bind between the guanine quartets.34
Figures 2A and 2B show the PAGE of SAwt at 5 and
100 mM potassium ion concentration and pH 6.5.
Under both conditions, SAwt shows a smearing of bands of
several molecular weights.
Two more prominent bands, migrating slower and faster
than the unfolded 20-mer oligonucleotide used as a control,
are observed.
Thus, the data indicate the presence of multiple species in
solution.
A possible explanation is the presence of multiple cytosines
in the SAwt sequence and then the possibility of impaired
duplex formation. An example is reported in Scheme 1.
In order to exclude the formation of impaired duplex and
to verify that the sequence studied can form a quadruplex
structure, two different strategies were undertaken:
a. Analysis of the SAwt sequence at low pH, where the for-
mation of double strand is hampered;
b. Study the behavior of a similar sequence, in which all
the cytosines are replaced by thymines, maintaining the
correct spacing between guanines nucleotides. Such a
sequence will be defined as SAmut (GGTTTGGTT
GGTTTTGG).
Here below, both approaches are evaluated in parallel for all
techniques used.
Concerning the natural sequence, SAwt, at pH 4.5 (Figures
2C and 2D) no heterogeneity is observed and a single band is
present, migrating faster than the control. This band could be
attributed to a quadruplex structure since in the presence of
saturating amount of potassium, which is known to induce the
formation of quadruplex structures, the intensity of this band
increases, suggesting a stabilization of the structure.
As far as the SAmut fragment is concerned, the band
observed at pH 6.5 did not give a clear indication. However,
the observation that at a pH as low as 4.5, a single band of low
mobility is observed suggests the formation of a single struc-
ture, different from the one observed for the SAwt fragment
since they have different mobility.
CD Analysis of the Putative Quadruplex Regions
Figure 3A shows the CD spectra of the native SAwt oligonu-
cleotide at pH 6.5 or 4.5.
At pH 6.5 the spectrum shows two positive peaks around
270 and 285 nm and a negative peak at 240 nm. Addition of
saturating amounts of potassium had no effect on the spec-
trum. It seems difficult to give an unambiguous interpretation
of these spectra, but some features resemble the poly(dGdC)-
poly(dGdC) and poly(dG)-poly(dC) previously observed with
different oligonucleotide DNA sequences.35,36 At pH 4.5, where
the formation of double strands is hampered, the spectrum of
SAwt shows a negative peak around 260 nm and strong posi-
tive peak at 290 nm that clearly indicate the presence of a
quadruplex structure.37,38 Addition of saturating amounts of
potassium has no further effects on the spectrum.
The previous data show that the oligonucleotide at pH 6.5
might form pairings typical of B-DNA, probably deriving from
the formation of impaired intermolecular pairings as suggested
by the previous electrophoresis data.
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This undesirable effect clearly occurs since hundreds of bil-
lions of molecules are present in vitro but cannot occur in vivo
where only two strands are present. Thus, we synthesized a dif-
ferent oligonucleotide, SAmut (GGTTTGGTTGGTTTTGG),
in which all cytosines and adenines have been substituted by
thymines but maintaining the right position of guanines. The
CD spectrum of this oligonucleotide is shown in Figure 3B.
Both at pH 6.5 and at pH 4.5, in the absence or in the presence
of saturating amounts of potassium, the spectra show a posi-
tive peak around 290 nm indicating the presence of preformed
quadruplex structures.
NMR Analysis of the Putative Quadruplex Regions
Figure 4A shows the NMR spectra collected at 278C for SAwt
at 200 lM concentration and different pH values in the
absence or in the presence of 100 mM KCl. At pH 6.5, the
chemical shifts observed for the imino protons are in 13.00 to
14.00 ppm range, indicative of the formation of double-
stranded DNA and/or G•C•G•C tetrads;39 there is no evidence
of quadruplex formation, characterized by a different chemical
shift range for imino protons. Since the isolated SAwt oligonu-
cleotide is not autocomplementary but contains several cyto-
sines, we attributed this secondary structure to the formation
of impaired alignments (see Scheme 1). This is in agreement
with the results obtained by CD and electrophoresis analysis.
The number and intensities of peaks in the 13.00 to 14.00 ppm
range increase after the addition of 100 mM potassium. Similar
spectra were collected at lower concentration of DNA (10 lM,
data not shown) to shift the equilibrium toward the single
strand in the absence of potassium and possibly toward quad-
ruplex in the presence of potassium but the results were the
same, indicating that impaired double strands are very stable.
The sample in the presence of a saturating amount of potas-
sium was then kept at 958C for 10 min and then slowly allowed
to anneal but the final secondary structure observed still sug-
gests the presence of double-stranded DNA (data not shown).
At lower pH, where the formation of double strands is ham-
pered, the SAwt oligonucleotide shows imino protons peaks in
the range 12.00 to 13.0 ppm that are clearly indicative of quad-
ruplex secondary structure, even in the presence of low
amounts of potassium. Since potassium is present in the
FIGURE 2 PAGE analysis of the quadruplex region. Native 15%
PAGE of SAwt, SAmut and Ctrl20 oligonucleotides in different pH
and salt conditions. A) pH 6.5, no KCl; B) pH 6.5, 100 mM KCl; C)
pH 4.5, no KCl; D) pH 4.5, 100 mM KCl. In each panel, lane 1 cor-
responds to a 20-nucleotide oligonucleotide unable to form G-
quadruplex, used as a control, while lanes 2 and 3 correspond to
SAwt and SAmut, respectively.
FIGURE 3 CD spectra of the quadruplex region. CD spectra of
(A) the wild-type 17-mer DNA oligonucleotide used in this study
(SAwt) and (B) the mutated 17-mer DNA oligonucleotide in which
all nonguanine nucleotides are substituted with thymines (SAmut).
The spectra are recorded at different pH and potassium concentra-
tion. The spectra at pH 6.5 are the brown (5 mM potassium phos-
phate buffer) and the orange line (5 mM potassium phosphate
buffer, 100 mM KCl). The spectra at pH 4.5 are the light blue
(5 mM potassium acetate buffer) and the dark blue line (5 mM
potassium acetate buffer, 100 mM KCl). In (A) the two positive
peaks at 260 nm and 290 nm are indicative of G-C double strand
formation while the small negative and positive peaks at 260 nm
and 290 nm are indicative of unimolecular quadruplex. In (B) the
negative and positive peaks at 260 nm and 290 nm are indicative of
quadruplex formation at pH 4.5.
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potassium acetate buffer, the formation of quadruplex struc-
ture appears already at minimal amounts of potassium. This is
in agreement with the CD data that suggest a quadruplex
structure under these conditions (Figure 3). Increasing the
potassium concentration induces small but detectable changes
in the NMR spectrum with small shift of some resonances and
different relative intensity of some signals. This could indicate
a slight rearrangement of the structure that could well explain
the differences observed in the CD spectra. Furthermore, low
intensity signals are observed in the same position of the sig-
nals observed at pH 6.5. Such signals could indicate a minor
form in equilibrium with the quadruplex.
To verify that the double-stranded structure observed at pH
6.5 arises from impaired GC alignment and “Watson-Crick”
bonds we also collected NMR spectra of SAmut, the mutant
oligonucleotide in which all adenines and cytosines were
replaced by thymines. The position of guanines is maintained
in this oligonucleotide but impaired alignments cannot be
formed. The spectra of this oligonucleotide at different pH val-
ues are reported in Figure 4B and show that the imino protons
peaks are in the range 11.5 to 12.5 ppm in the presence of
potassium both at neutral and at acidic conditions. This find-
ing indicates the absence of B-DNA formation and the forma-
tion of a typical quadruplex DNA in all conditions. The broad
peak around 11.5 ppm is indicative of residual, unfolded,
DNA.
These results clearly indicate the formation of quadruplex
structures for both DNA oligonucleotides.
Thermal Denaturation of the Putative Quadruplex
Region
To gain further insight we analyzed the melting profiles of the
SAwt fragment present in the human genome. Figure 5 shows
the melting curves of SAwt. At pH 4.5 the calculated Tm at
5 mM and 100 mM potassium are about 55.58C and 54.88C,
respectively. These values are compatible with the formation of
a unimolecular quadruplex as suggested by the previous data.
At pH 6.5 the Tm in the presence of 5 and 100 mM potassium
are 68.58C and 73.88C, respectively. These values are unusually
high for a 17-mer and may reflect the formation of multi-
stranded DNA structures.
SAwt Oligonucleotide Sequence is Conserved Among
Primates and Mammalians
We identified six loci in the human genome showing 100%
identity with the SAwt sequence of hs1.2 enhancers in the
30RRs (Table II). One of the six loci maps in a large gene-
desert region with unidentified function, a second one is
within the translated sequence of DCAF12L1 (a member of the
WD repeat protein family), and the four others map in tran-
scribed regulatory regions, just like the two hs1.2 copies (Table
II). However, when alignment to primate or mammal genome
FIGURE 4 NMR spectra of the quadruplex region. 1H NMR spec-
tra of (A) SAwt and (B) SAmut recorded at different pH and potas-
sium concentrations. Brown spectra refers to pH 6.5, 5 mM
potassium phosphate buffer; orange spectra refers to pH 6.5, 5 mM
potassium phosphate buffer, 100 mM KCl; light blue spectra refers
to pH 4.5, 5 mM potassium acetate buffer; dark blue spectra refers
to pH 4.5, 5 mM potassium acetate buffer, 100 mM KCl. Peaks from
13.0 to 14.0 ppm are indicative of double strand formation; narrow
peaks between 11.5 and 13.0 ppm are indicative of quadruplex for-
mation. The broad peak around 11.5 ppm belongs to unstructured
DNA.
FIGURE 5 Melting analysis of the quadruplex region. CD Melting
curves of SAwt collected at different pH and different potassium
concentrations. Brown, pH 6.5, 5 mM potassium phosphate buffer;
orange, pH 6.5, 5 mM potassium phosphate buffer, 100 mM KCl;
light blue, pH 4.5, 5 mM potassium acetate buffer; dark blue, pH
4.5, 5 mM potassium acetate buffer, 100 mM KCl.
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of each of the SAwt-similar loci is considered, some interesting
indications can be found. In nonhuman primates, all six
sequences show some variation with respect to the SAwt
sequence that alter the four GG pairs needed for the quadru-
plex formation, suggesting relaxed selection in these species at
those loci. By contrast, when the 3’RR1 and 3’RR2 loci are con-
sidered, the GG pairs are conserved in all primates and in
many mammal genomes (Tables I and II), suggesting a strong
negative selection against mutations at these positions and in
turn a possible conserved functional role of this fragment of
the enhancer.
DISCUSSION
Different DNA conformations modify the availability of con-
sensus sequences for the binding of specific proteins and 3D
structures in the binding region which can finely tune the
binding process.5,27,30,41–43 In many cases, the DNA molecule
must be in an open and accessible state to allow the binding of
specific proteins and the 3D structures cooperate to define the
actual condition of the embedded consensus sites. This process
has been called chromatin remodeling and requires the activity
of proteins necessary to maintain the chromatin in an accessi-
ble state for nuclear factors like NF-kB.41 Specific chromatin
modifications and configurations are in fact necessary for NF-
kB proteins to bind cognate kB motifs.28 Thus, the presence of
kB sites appears to be a requirement but is not sufficient for
gene induction.40 The effectiveness of the consensus site is
influenced by the genomic and nuclear environment in which
it is embedded.42
We previously observed the possibility of a 3D palindromic
structure that could modulate the role of the 3’RR by forma-
tion of a hairpin structure, in which the hs1.2 enhancer locates
at the middle of the apical loop.8 This site was probably also
tandem-repeated in the Catarrhini-parvorder ancestor, in
which also the VNTR of hs1.2 originated.8 These remarks sug-
gest that the current version of the enhancer may have evolved
from an ancestral sequence including the core and a single
copy of the quadruplex site.
In this article, we show that a quadruplex structure might
form inside the hs1.2 enhancers in the 3’RRs (Figures 2 and 3)
and we speculate a possible functional role for it in exposing
DNA in order to modulate the binding of transcription factors.
We show that the hs1.2 short oligonucleotide required for the
quadruplex structure formation is highly conserved in prima-
tes and mammals, unlike other identical sequences in the
human genome, suggesting that strong negative selection is
acting on this region and corroborating the hypothesis of a
functional role of the quadruplex 3D structures.
The formation of a quadruplex structure indicates the pres-
ence of a newly identified functional region within the hs1.2
enhancer. Quadruplex formation in Igs had been speculated
many years ago,44 and the present work gives some experimen-
tal evidence of such structure. This finding allows the formula-
tion of hypotheses on the function of this polymorphic
enhancer suggesting a possible modulating effect in the equi-
librium among the alternative 3D forms that can modulate the
binding of NF-kB and SP1 nuclear factor. The predicted quad-
ruplex sequence in fact lies just upstream of the NF-kB tran-
scription factor consensus site (Figure 1C). In this context it
must be noted that both NF-kB and Sp1 bind to double-
stranded DNA. Thus, a possible role of the quadruplex struc-
ture may be to shift the equilibrium of the 3’RR region towards
the hairpin structure, stabilizing this alternative conformation
of the DNA. The final effect of this conformational change is
the inhibition of transcription factors binding since the DNA
is single-stranded. An alternative possibility is the formation of
a local 3D structure, the quadruplex, along the double-
stranded helix, which creates a steric hindrance to the binding
of transcription factors to their consensus sites.
These results support our previous findings on physiologic
and pathologic phenotypes that clarified the modulatory func-
tion of the hs1.2 alleles in Ig production. Taken together, these
studies reveal the relevant role of the 3D structures of DNA for
regulation of Igh expression and B cell activity.
MATERIALS AND METHODS
In Silico Analyses of hs1.2 Sequence
We searched for copies of the hs1.2 enhancer in three Genbank data-
bases (i.e. genome, htgs, and wgs) by the NCBI Blast algorithm
(http://blast.ncbi.nlm.nih.gov/).50 The Genomic Evolutionary Rate
Profiling (GERP) score, Single Nucleotide Polymorphisms (SNPs),
repeat, and 3’RRs features are analyzed, identified and/or graphically
visualized using the UCSC Genome Browser46 (http://genome.ucsc.
edu/cgi-bin/hgGateway). The G-quadruplex structure consensus sites
were identified by Quadbase47 (http://quadbase.igib.res.in) and QGRS
Mapper48 (http://bioinformatics.ramapo.edu/QGRS).
Spectroscopic Analysis of the DNA Sequence
For the in vitro analysis we used two oligonucleotides derived from
the polymorphic region of hs1.2 enhancer in the human 3’RRs (Figure
1A; detailed view of the 3’RR1 in Figure 1B): a sequence of 17 nucleo-
tides (17-mer, SAwt: GGCCAGGCTGGCCCAGG) selected as a G-
quadruplex putative consensus sequence from in silico analysis (Fig-
ure 1C); the second oligonucleotide was designed to replace all the C
and A in the SAwt with T (SAmut: GGTTTGGTTGGTTTTGG). Both
oligonucleotides were synthesized by Eurofins (Milano, Italy), purified
by HPLC and desalted. Samples were denatured at 958C for 10 min
and then slowly cooled before use. Circular dichroism (CD) and
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nuclear magnetic resonance (NMR) spectra at pH 6.5 were obtained
by dissolving the sample in 5 mm potassium phosphate buffer, while
the spectra at pH 4.5 were obtained by dissolving the sample in 5 mM
potassium acetate buffer. KCl was added from 3M stock solutions and
spectra were collected soon after the addition of potassium. CD spec-
tra were collected on a Jasco J600 Spectrometer (Jasco Inc., Easton,
MD) using a 0.1 cm path cell at 300 K. Data were obtained from 200
to 340 nm at 0.2 nm interval, 20 nm/min speed, and averaging over
four scans. Samples contained 20 lM of DNA. Data are reported as
mean residue ellipticity. NMR spectra were collected using concentra-
tions ranging from 10 to 200 lM at 400 or 600 MHz on Bruker or
Varian spectrometers, respectively. A 10% D2O was used for lock and
water was suppressed by using a watergate pulse sequence49 that gives
a maximum excitation over the imino proton region. The spectra
were collected at different temperatures ranging from 2 to 278C and
analysis was done using the MNova software (Mestrelab Research,
Spain).
Polyacrylamide Gel Electrophoresis (PAGE)
PAGE analysis has been carried out as previously described.50 The
samples (5 mM oligonucleotides in 5 mM potassium acetate buffer,
pH 4.5 or 6.5) were heated to 958C for 10 min, and then annealed by
slowly cooling to room temperature with or without 100 mM KCl.
After incubation at 48C for at least 1 h, the samples were run on 18%
native PAGE (19:1 acrylamide:bisacrylamide ratio) with TAE as elec-
trophoretic running buffer, containing the same salt concentration of
the run samples. Each run was performed at room temperature for
about 1 h and 30 min at 130 V. The gels were stained with SYBR Safe
DNA gel stain (Invitrogen).
CD Melting Analysis
CD spectra were recorded using a JASCO J-715 spectropolarimeter
equipped with a Peltier temperature controller, using a quartz cell of
1.0 cm optical path length, in the range 20 to 958C, increasing the
temperature with a 18C increasing step per minute. The CD melting
profiles were obtained plotting the molar ellipticity corresponding to
the maximum at about 290 nm as a function of temperature. The
resulting curves were normalized obtaining a plot of the folded frac-
tion, a, versus temperature. The melting temperature (Tm) was then
deduced as the temperature corresponding to a equal to 0.5.
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